NCT06528704 The Impact of Real Time Ventilation Feedback on Ventilation Rate and Tidal Volume During Cardiac Arrest.
| NCT ID | NCT06528704 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Ghent |
| Condition | Cardiac Arrest |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-05-20 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-05-20 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
During out-of-hospital cardiopulmonary resuscitation, patient are first ventilated without ventilation feedback (but with a flowsensor connected), hereafter patients are ventilated with the use of ventilation feedback.
Eligibility Criteria
Inclusion Criteria: \- Exclusion Criteria: Traumatic cardiac arrest Inability to intubate patient
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06528704 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06528704 currently recruiting?
Yes, NCT06528704 is actively recruiting participants. Contact the research team at maxim.vanwulpen@uzgent.be for enrollment information.
Where is the NCT06528704 trial being conducted?
This trial is being conducted at Knokke, Belgium, Ghent, Belgium.
Who is sponsoring the NCT06528704 clinical trial?
NCT06528704 is sponsored by University Hospital, Ghent. The trial plans to enroll 100 participants.